BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11880452)

  • 21. [Disseminated fusarium infection in two neutropenic children].
    Petit A; Tabone MD; Moissenet D; Auvrignon A; Landman-Parker J; Boccon-Gibod L; Leverger G
    Arch Pediatr; 2005 Jul; 12(7):1116-9. PubMed ID: 15964527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disseminated fungemia due to Candida krusei with cutaneous lesions and successful treatment by amphotericin B lipid complex and catheter removal: a case report.
    Hourez R; Gillard PH; Mariat P; Aoun M
    Int J Infect Dis; 2002 Dec; 6(4):326-8. PubMed ID: 12725216
    [No Abstract]   [Full Text] [Related]  

  • 23. Successful treatment of disseminated fusariosis with high dose liposomal amphotericin-B in a patient with acute lymphoblastic leukemia.
    Cudillo L; Tendas A; Picardi A; Dentamaro T; Del Principe MI; Amadori S; de Fabritiis P
    Ann Hematol; 2006 Feb; 85(2):136-8. PubMed ID: 16220312
    [No Abstract]   [Full Text] [Related]  

  • 24. Successful treatment of disseminated Fusarium infection in an immunocompromised child.
    Barrios NJ; Kirkpatrick DV; Murciano A; Stine K; Van Dyke RB; Humbert JR
    Am J Pediatr Hematol Oncol; 1990; 12(3):319-24. PubMed ID: 2240479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amphotericin B lipid complex at 3 mg/kg/day for treatment of invasive fungal infections in adults with haematological malignancies.
    Martino R; Subirá M; Sureda A; Sierra J
    J Antimicrob Chemother; 1999 Oct; 44(4):569-72. PubMed ID: 10588324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid complexes of amphotericin B: the competitive picture.
    Richardson MD
    J Med Microbiol; 1997 Mar; 46(3):185-7. PubMed ID: 9126817
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy of amphotericin B lipid complex injection (ABLC) in bone marrow transplant recipients with life-threatening systemic mycoses.
    Wingard JR
    Bone Marrow Transplant; 1997 Feb; 19(4):343-7. PubMed ID: 9051244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of amphotericin B lipid complex in 548 children and adolescents with invasive fungal infections.
    Wiley JM; Seibel NL; Walsh TJ
    Pediatr Infect Dis J; 2005 Feb; 24(2):167-74. PubMed ID: 15702047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fatal disseminated fusarium infection in acute lymphoblastic leukaemia in complete remission.
    Austen B; McCarthy H; Wilkins B; Smith A; Duncombe A
    J Clin Pathol; 2001 Jun; 54(6):488-90. PubMed ID: 11376027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The experience is CLEAR.
    Chandrasekar P
    Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():31-5. PubMed ID: 16707248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted prophylaxis with amphotericin B lipid complex in liver transplantation.
    Singhal S; Ellis RW; Jones SG; Miller SJ; Fisher NC; Hastings JG; Mutimer DJ
    Liver Transpl; 2000 Sep; 6(5):588-95. PubMed ID: 10980058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disseminated visceral fusariosis treated with amphotericin B-phospholipid complex.
    Engelhard D; Eldor A; Polacheck I; Hardan I; Ben-Yehuda D; Amselem S; Salkin IF; Lopez-Berestein G; Sacks T; Rachmilewitz EA
    Leuk Lymphoma; 1993 Mar; 9(4-5):385-92. PubMed ID: 8348074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amphotericin B Lipid Complex (Abelcet) in the treatment of invasive mycoses: the North American experience.
    Lister J
    Eur J Haematol Suppl; 1996; 57():18-23. PubMed ID: 8706812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful treatment of Candida glabrata endophthalmitis with amphotericin B lipid complex (ABLC).
    Darling K; Singh J; Wilks D
    J Infect; 2000 Jan; 40(1):92-4. PubMed ID: 10762120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies--a randomized, controlled trial.
    Subirà M; Martino R; Gómez L; Martí JM; Estany C; Sierra J
    Eur J Haematol; 2004 May; 72(5):342-7. PubMed ID: 15059069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antifungal compounds: controversies, queries and conclusions.
    Graybill JR; Tollemar J; Torres-Rodríguez JM; Walsh TJ; Roilides E; Farmaki E
    Med Mycol; 2000; 38 Suppl 1():323-33. PubMed ID: 11204160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of fungal infections with ABLC in the home-care setting.
    Weissmann AC
    J Assoc Nurses AIDS Care; 1999; 10(3):43-52. PubMed ID: 10707695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Successful treatment of disseminated fusariosis in a febrile neutropenic patient with combined antifungal therapy of voriconazol plus amphotericin B deoxycholate].
    Olivares R; Luppi M; Díaz MC
    Rev Chilena Infectol; 2018 Aug; 35(4):448-452. PubMed ID: 30534934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex.
    Perfect JR
    Clin Infect Dis; 2005 May; 40 Suppl 6():S401-8. PubMed ID: 15809926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Case report: a Fusarium fungaemia].
    Yücesoy M; Ergon MC; Oren H; Gülay Z
    Mikrobiyol Bul; 2004 Jul; 38(3):265-71. PubMed ID: 15490848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.